Related references
Note: Only part of the references are listed.Development, validation and use of ELISA for antibodies to human alpha-1 antitrypsin
Guo-jie Ye et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Estimating the ratio of CD4+to CD8+T cells using high-throughput sequence data
Ryan Emerson et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Safety and Feasibility of High-pressure Transvenous Limb Perfusion With 0.9% Saline in Human Muscular Dystrophy
Zheng Fan et al.
MOLECULAR THERAPY (2012)
Epigenetic quantification of tumor-infiltrating T-lymphocytes
Jalid Sehouli et al.
EPIGENETICS (2011)
Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production Method
Jeffrey D. Chulay et al.
HUMAN GENE THERAPY (2011)
Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results
Terence R. Flotte et al.
HUMAN GENE THERAPY (2011)
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
Peter A. LeWitt et al.
LANCET NEUROLOGY (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
Valder R. Arruda et al.
BLOOD (2010)
Lack of Immunotoxicity After Regional Intravenous (RI) Delivery of rAAV to Nonhuman Primate Skeletal Muscle
Alice Toromanoff et al.
MOLECULAR THERAPY (2010)
A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
Shin-ichi Muramatsu et al.
MOLECULAR THERAPY (2010)
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan S. Robins et al.
BLOOD (2009)
Redefining Chronic Viral Infection
Herbert W. Virgin et al.
CELL (2009)
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors
Gary C. Pien et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
Daniel E. Kaufmann et al.
JOURNAL OF IMMUNOLOGY (2009)
Detection of Intact rAAV Particles up to 6 Years After Successful Gene Transfer in the Retina of Dogs and Primates
Knut Stieger et al.
MOLECULAR THERAPY (2009)
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
Mark L. Brantly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Analysis of FOXP3+ Regulatory T Cells That Display Apparent Viral Antigen Specificity during Chronic Hepatitis C Virus Infection
Shuo Li et al.
PLOS PATHOGENS (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients
Erik S. Stroes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth et al.
HUMAN GENE THERAPY (2008)
Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection
Hirotoshi Ebinuma et al.
JOURNAL OF VIROLOGY (2008)
Safety and efficacy of regional intravenous (RI) versus intramuscular (IM) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle
Alice Toromanoff et al.
MOLECULAR THERAPY (2008)
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
J. L. Eberling et al.
NEUROLOGY (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy
Louise R. Rodino-Klapac et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillornavirus antigens
Sjoerd H. van der Burg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
Activation of CD4(+)CD25(+) regulatory T cell suppressor function by analogs of the selecting peptide
Joseph Larkin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 α1-antitrypsin (AAT) vector in AAT-deficient adults
Mark L. Brantly et al.
HUMAN GENE THERAPY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes
J Endl et al.
DIABETES (2006)
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients
L Weiss et al.
BLOOD (2004)
CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons
AJ MacDonald et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
MS Jordan et al.
NATURE IMMUNOLOGY (2001)
Share Paper
